Gynaekologisch-Onkologische Schwerpunktpraxis

Research site

Germany Pelikanplatz 23, 30177, Germany

HER2 positive breast cancer
Adult patients

About Specializations

Gynaekologisch-Onkologische Schwerpunktpraxis in Germany specialises in clinical trials of conditions such as HER2 positive breast cancer, and other specialisations. This site conducts important research.

HER2 positive breast cancer

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Pelikanplatz 2330177Germany

Open in maps ↗

Recruiting now: no trials
Conditions studied: 1

More sites in Germany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

1 clinical trial

HER2 positive breast cancer

Not recruiting

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites